NeuBase Therapeutics Inc (NBSE)
0.42
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.42
0.00 (0.00%)
After-Hours: 20:00
NeuBase Therapeutics Cash from Operations (TTM): -14.78M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -14.78M |
| June 30, 2023 | -19.42M |
| March 31, 2023 | -24.69M |
| December 31, 2022 | -29.43M |
| September 30, 2022 | -29.01M |
| June 30, 2022 | -27.82M |
| March 31, 2022 | -25.03M |
| December 31, 2021 | -20.36M |
| September 30, 2021 | -18.87M |
| June 30, 2021 | -17.00M |
| March 31, 2021 | -13.75M |
| December 31, 2020 | -12.05M |
| September 30, 2020 | -10.71M |
| June 30, 2020 | -7.739M |
| March 31, 2020 | -5.559M |
| December 31, 2019 | -4.720M |
| September 30, 2019 | -2.846M |
| June 30, 2019 | -2.845M |
| March 31, 2019 | -3.322M |
| December 31, 2018 | -5.864M |
| September 30, 2018 | -9.492M |
| June 30, 2018 | -14.17M |
| March 31, 2018 | -17.11M |
| December 31, 2017 | -17.56M |
| September 30, 2017 | -19.29M |
| Date | Value |
|---|---|
| June 30, 2017 | -19.05M |
| March 31, 2017 | -19.11M |
| December 31, 2016 | -18.59M |
| September 30, 2016 | -15.99M |
| June 30, 2016 | -13.16M |
| March 31, 2016 | -10.66M |
| December 31, 2015 | -11.28M |
| September 30, 2015 | -10.69M |
| June 30, 2015 | -10.06M |
| March 31, 2015 | -10.33M |
| December 31, 2014 | -6.806M |
| September 30, 2014 | -5.360M |
| June 30, 2014 | -4.707M |
| March 31, 2014 | -3.488M |
| December 31, 2013 | -3.321M |
| September 30, 2013 | -2.690M |
| June 30, 2013 | -2.285M |
| March 31, 2013 | -1.982M |
| December 31, 2012 | -2.191M |
| September 30, 2012 | -1.754M |
| June 30, 2012 | -1.643M |
| March 31, 2012 | -1.448M |
| December 31, 2011 | -1.066M |
| September 30, 2011 | -1.004M |
| June 30, 2011 | -0.7514M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-29.43M
Minimum
Dec 2022
-2.845M
Maximum
Jun 2019
-15.92M
Average
-15.89M
Median
Cash from Operations (TTM) Benchmarks
| Ampio Pharmaceuticals Inc | -8.564M |
| Stoke Therapeutics Inc | -81.07M |
| ABVC BioPharma Inc | -4.236M |
| MAIA Biotechnology Inc | -13.07M |
| Aprea Therapeutics Inc | -12.18M |